121 related articles for article (PubMed ID: 1398748)
1. Adult T-cell leukaemia-derived factor/thioredoxin expression on the HTLV-I transformed T-cell lines: heterogeneous expression in ALT-2 cells.
Makino S; Masutani H; Maekawa N; Konishi I; Fujii S; Yamamoto R; Yodoi J
Immunology; 1992 Aug; 76(4):578-83. PubMed ID: 1398748
[TBL] [Abstract][Full Text] [Related]
2. IL-2 receptor and Fc epsilon R2 gene activation in lymphocyte transformation: possible roles of ATL-derived factor.
Yodoi J; Tagaya Y; Masutani H; Maeda Y; Kawabe T
Princess Takamatsu Symp; 1988; 19():73-86. PubMed ID: 2978620
[TBL] [Abstract][Full Text] [Related]
3. TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines.
Okada M; Maeda M; Tagaya Y; Taniguchi Y; Teshigawara K; Yoshiki T; Diamantstein T; Smith KA; Uchiyama T; Honjo T
J Immunol; 1985 Dec; 135(6):3995-4003. PubMed ID: 2999237
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors.
U-Taniguchi Y; Furuke K; Masutani H; Nakamura H; Yodoi J
Oncol Res; 1995; 7(3-4):183-9. PubMed ID: 8555652
[TBL] [Abstract][Full Text] [Related]
5. IL-2 receptor(p55)/Tac-inducing factor. Purification and characterization of adult T cell leukemia-derived factor.
Tagaya Y; Okada M; Sugie K; Kasahara T; Kondo N; Hamuro J; Matsushima K; Dinarello CA; Yodoi J
J Immunol; 1988 Apr; 140(8):2614-20. PubMed ID: 2895791
[TBL] [Abstract][Full Text] [Related]
6. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.
Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J
J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223
[TBL] [Abstract][Full Text] [Related]
7. Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells.
Ueda M; Imada K; Imura A; Koga H; Hishizawa M; Uchiyama T
Br J Haematol; 2005 Jan; 128(2):169-76. PubMed ID: 15638850
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of ADF/thioredoxin in human serum and its clinical significance].
Kitaoka Y; Sachi Y; Mori T; Yodoi J
Rinsho Byori; 1994 Aug; 42(8):853-9. PubMed ID: 7933622
[TBL] [Abstract][Full Text] [Related]
9. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
Wakasugi N; Tagaya Y; Wakasugi H; Mitsui A; Maeda M; Yodoi J; Tursz T
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979
[TBL] [Abstract][Full Text] [Related]
10. Expression and co-cytokine function of murine thioredoxin/adult T cell leukaemia-derived factor (ADF).
Blum H; Röllinghoff M; Gessner A
Cytokine; 1996 Jan; 8(1):6-13. PubMed ID: 8742061
[TBL] [Abstract][Full Text] [Related]
11. Redox control of Epstein-Barr virus replication by human thioredoxin/ATL-derived factor: differential regulation of lytic and latent infection.
Sono H; Teshigawara K; Sasada T; Takagi Y; Nishiyama A; Ohkubo Y; Maeda Y; Tatsumi E; Kanamaru A; Yodoi J
Antioxid Redox Signal; 1999; 1(2):155-65. PubMed ID: 11228744
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation.
Nagasaki M; Zhang J; Morikawa S; Harada T; Nabika T; Tanaka Y
Pathol Int; 2005 May; 55(5):264-72. PubMed ID: 15871724
[TBL] [Abstract][Full Text] [Related]
13. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
[TBL] [Abstract][Full Text] [Related]
14. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction.
Tagaya Y; Maeda Y; Mitsui A; Kondo N; Matsui H; Hamuro J; Brown N; Arai K; Yokota T; Wakasugi H
EMBO J; 1989 Mar; 8(3):757-64. PubMed ID: 2785919
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress induces adult T cell leukemia derived factor/thioredoxin in the rat retina.
Ohira A; Honda O; Gauntt CD; Yamamoto M; Hori K; Masutani H; Yodoi J; Honda Y
Lab Invest; 1994 Feb; 70(2):279-85. PubMed ID: 8139268
[TBL] [Abstract][Full Text] [Related]
16. Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia.
Ohtsubo H; Arima N; Matsushita K; Hidaka S; Fujiwara H; Arimura K; Kukita T; Fukumori J; Matsumoto T; Eizuru Y; Tanaka H
Exp Hematol; 1997 Nov; 25(12):1246-52. PubMed ID: 9357968
[TBL] [Abstract][Full Text] [Related]
17. ADF (adult T cell leukemia-derived factor)/human thioredoxin and viral infection: possible new therapeutic approach.
Masutani H; Nakamura H; Ueda Y; Kitaoka Y; Kawabe T; Iwata S; Mitsui A; Yodoi J
Adv Exp Med Biol; 1992; 319():265-74. PubMed ID: 1329444
[TBL] [Abstract][Full Text] [Related]
18. Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: involvement of dithiol related reduction.
Tagaya Y; Wakasugi H; Masutani H; Nakamura H; Iwata S; Mitsui A; Fujii S; Wakasugi N; Tursz T; Yodoi J
Mol Immunol; 1990 Dec; 27(12):1279-89. PubMed ID: 2177148
[TBL] [Abstract][Full Text] [Related]
19. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
Ishikawa C; Matsuda T; Okudaira T; Tomita M; Kawakami H; Tanaka Y; Masuda M; Ohshiro K; Ohta T; Mori N
Br J Haematol; 2007 Feb; 136(3):424-32. PubMed ID: 17233845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
